ATRA - Atara Biotherapeutics, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
No. of analysts11111111
Avg. Estimate-1.2-1.15-4.64-4.11
Low estimate-1.48-1.37-5.34-5.29
High estimate-0.99-0.94-4.14-3.07
Year ago EPS-1.6-1.31-5.67-4.64
Revenue estimateCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
No. of analysts10101010
Avg. EstimateN/AN/AN/A7.83M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A44.23M
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/201929/09/201930/12/201930/03/2020
Est. EPS-1.5-1.44-1.34-1.41
Actual EPS-1.6-1.31-1.36-1.2
Difference-0.10.13-0.020.21
Surprise %-6.70%9.00%-1.50%14.90%
EPS trendCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
Current estimate-1.2-1.15-4.64-4.11
7 days ago-1.2-1.15-4.64-4.11
30 days ago-1.24-1.18-4.72-4.08
60 days ago-1.38-1.31-5.31-4.57
90 days ago-1.38-1.31-5.31-4.57
EPS revisionsCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesATRAIndustrySector(s)S&P 500
Current qtr.25.00%N/AN/AN/A
Next qtr.12.20%N/AN/AN/A
Current year18.20%N/AN/AN/A
Next year11.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more